|
|
Last Modified on Aug 03, 2026
If you are convicted of a drug crime, you may have more options than you are aware of. Depending on your situation, you may qualify for the federal Residential Drug Abuse Program (RDAP), which can reduce a federal inmate’s sentence upon completion. While not an immediate method of release or expungement, the RDAP program can be a viable option if you qualify. You may be asking: What is the federal RDAP program, and who qualifies?
Having a skilled federal drug trafficking attorney in your corner while you pursue acceptance into the RDAP program can make it easier to navigate the laws that could impact your sentence. Federal drug trafficking cases can be complex and overwhelming to deal with on your own, especially after a conviction.
Our firm can devote decades of focused criminal defense experience to your case and assist you through every step of the RDAP. A skilled Pennsylvania criminal defense attorney can lay the foundation pre-conviction for acceptance into the program and can advocate for you post-conviction for entry into RDAP.

What Is the Federal Residential Drug Abuse Program?
The Residential Drug Abuse Program (RDAP) is a prison inmate sentence reduction program established by the Federal Bureau of Prisons (BOP). It’s arguably their most intensive substance abuse treatment program and is only intended for drug crime inmates who qualify.
It involves the use of cognitive behavioral therapy, and successful completion can reduce a federal inmate’s sentence by up to one year and secure an extended halfway house placement to finish the community treatment program.
There are currently six federal locations in Pennsylvania that offer the RDAP program for inmates as an intensive nine- to twelve-month treatment program. Drug crimes accounted for 43.1% of all criminal sentences in Pennsylvania in 2024, so the potential use of the RDAP program is not uncommon.